Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-09-16

Clinical Trial Update: A Study of TRV130 for the Treatment of Pain After Bunionectomy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating TRV130 for pain after bunionectomy has completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRV130 (oliceridine)

Snippet

Sponsor: Trevena Inc. | Conditions: Acute Pain | Phase 2 | Status: COMPLETED | Results posted: 2020-09-16